title: Metered-dose inhaler technique per the Global Initiative for Asthma and Expert Panel Report 3: Why do pharmaceutical companies have one critical difference?
authors.affiliation: Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee. Electronic address: tself@uthsc.edu.
authors.forename: Timothy H
authors.initials: TH
authors.lastname: Self
authors.affiliation: Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Hoth
authors.affiliation: Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
authors.forename: J Michael
authors.initials: JM
authors.lastname: Bolin
authors.affiliation: UT Le Bonheur Pediatric Asthma and Allergy Clinic, LeBonheur Children's Hospital, Memphis, Tennessee.
authors.forename: Charles
authors.initials: C
authors.lastname: Stewart
mesh_terms: D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy*; D004345:Drug Industry; D006801:Humans; D036501:Metered Dose Inhalers / Q000706:statistics & numerical data*; D009330:Nebulizers and Vaporizers; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*